Log In
BCIQ
Print this Print this
 

PTI-80 (formerly Exebryl-1)

  Manage Alerts
Collapse Summary General Information
Company ProteoTech Inc.
DescriptionSmall molecule targeting beta amyloid protein accumulation
Molecular Target Beta amyloid
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
PartnerTasly Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/11/2010

Undisclosed

Undisclosed

0

Get a free BioCentury trial today